Ingevity Corp 8-K Filing
Ticker: NGVT · Form: 8-K · Filed: 2025-11-05T00:00:00.000Z
Sentiment: neutral
Filing Stats: 548 words · 2 min read · ~2 pages · Grade level 12.1 · Accepted 2025-11-05 16:35:58
Key Financial Figures
- $0.01 — ange on which registered Common Stock ($0.01 par value) NGVT New York Stock Exchange
Filing Documents
- ngvt-20251105.htm (8-K) — 28KB
- ex99109302025.htm (EX-99.1) — 567KB
- image1a.jpg (GRAPHIC) — 143KB
- ngvt-20251105_g1.jpg (GRAPHIC) — 143KB
- 0001653477-25-000124.txt ( ) — 1234KB
- ngvt-20251105.xsd (EX-101.SCH) — 2KB
- ngvt-20251105_lab.xml (EX-101.LAB) — 21KB
- ngvt-20251105_pre.xml (EX-101.PRE) — 12KB
- ngvt-20251105_htm.xml (XML) — 3KB
02. RESULTS OF OPERATIONS AND FINANCIAL CONDITION
ITEM 2.02. RESULTS OF OPERATIONS AND FINANCIAL CONDITION On November 5, 2025 , Ingevity Corporation ("Ingevity") announced its preliminary financial results for the three and nine months ended September 30, 2025 which are attached as Exhibit 99.1 to this Current Report on Form 8-K. Please refer to our website for additional information regarding Ingevity. Periodically we may provide other information on the investor relations page of our website. Interested parties are encouraged to visit Ingevity's website to view such other information including Ingevity slide presentations. The information contained in Item 2.02 of this report, including Exhibit 99.1, is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities and Exchange Act of 1934, as amended, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.
01. FINANCIAL STATEMENTS AND EXHIBITS
ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS (d) Exhibits. Exhibit No. Description of Exhibit 99.1 Press release dated November 5, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. INGEVITY CORPORATION (Registrant) By: /S/ MARY DEAN HALL Mary Dean Hall Executive Vice President and Chief Financial Officer Date: November 5, 2025